CE-IVD, US-IVD
The cobas® KRAS Mutation Test offers broad mutation coverage of KRAS codons 12, 13 and 61 to identify colorectal cancer patients who are not likely to respond to anti-EGFR monoclonal antibody therapies.
CE-IVD, US-IVD
Access package inserts through your country’s Roche Diagnostics Website.